Legacy Healthcare expands in China
TPP Healthcare successfully partners Legacy Healthcare, a Swiss-based R&D firm, with Maxhealth, a Chinese commercial healthcare firm.
In China, March 15-17 2018, we will be hosting 100 Western healthcare companies specializing in innovative technologies in areas that are vital to the growing Chinese healthcare industry, along with approximately 1,000 Chinese healthcare strategic partners and investors.
Access the latest news, insight and market moves from TPP and across the industry.
SPECIALIZING IN GLOBAL DEAL-FLOW, TARGETED AT CHINA’S BOOMING HEALTHCARE MARKET
China is relevant, accessible and seeking innovation.
The numbers are only growing across the board for healthcare needs and innovative opportunity.
Work with us and expect real partners, deal-flow, results and progress.
TPP Healthcare prides itself as the leading platform to facilitate partnerships between both innovator and investor.
With an experienced team of well-connected industry veterans from all over the world, and the largest network in China’s healthcare industry, TPP has become the market expert with the top-notch network to execute and support cross-border transactions involving pharmaceuticals, medical devices and diagnostics.
TPP has the background, credentials and understanding to execute and support transactions involving global healthcare. Our team of analysts can quickly evaluate the potential for your company or product. Contact us today to discuss immediate opportunities – or simply sign up for our quarterly reports, client break-throughs and more.
THE PHARMA PARTNERS HEALTHCARE